Cash from financing is the cash generated/spent from financial activities such as share issuance (buy back), debt issuance (repayment), and dividends paid to preferred and common stockholders.
For the
six
months ended in Dec. 2023,
Sisram Medical paid$0.0 Mil more to buy back shares than it received from issuing new shares.
It spent$0.5 Mil paying down its debt.
It paid$0.0 Mil more to buy back preferred shares than it received from issuing preferred shares.
It received$0.0 Mil from paying cash dividends to shareholders.
It spent$11.9 Mil on other financial activities.
In all, Sisram Medicalspent$12.4 Mil on financial activities for the
six
months ended in Dec. 2023.
Sisram Medical Cash Flow from Financing Historical Data
The historical data trend for Sisram Medical's Cash Flow from Financing can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Sisram Medical Cash Flow from Financing Calculation
This is the cash generated/spent from financial activities such as share issuance (buy back), debt issuance (repayment), and dividends paid to preferred and common stockholders. In the calculation of free cash flow, cash from financing is not calculated because it is not related to operating activities.
Sisram Medical's Cash from Financing for the fiscal year that ended in Dec. 2023 is calculated as:
Cash Flow from Financing for the trailing twelve months (TTM) ended in Dec. 2023 adds up the semi-annually data reported by the company within the most recent 12 months, which was $-21.0 Mil.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Sisram Medical (OTCPK:SRAMF) Cash Flow from Financing Explanation
Cash from financing contains six items:
1. Issuance of Stock:
A company may raise cash from issuing new shares. Issuance of stock represents the cash inflow from offering common stock, which is the additional capital contribution to the entity during the period.
Sisram Medical's issuance of stock for the
six
months ended in Dec. 2023 was $0.0 Mil.
2. Repurchase of Stock:
A company may raise cash from issuing new shares. It can also use cash to buy back shares. Repurchase of stock represents the cash outflow to reacquire common stock during the period.
Sisram Medical's repurchase of stock for the
six
months ended in Dec. 2023 was $0.0 Mil.
3. Net Issuance of Debt:
Net issuance of debt is the cash a company received or spent through debt related activities such as debt issuance or debt repayment. If a company pays down its debt during the period, this number will be negative. If a company issued more debt, it receives cash and this number is positive.
Sisram Medical's net issuance of debt for the
six
months ended in Dec. 2023 was $-0.5 Mil.
Sisram Medical spent$0.5 Mil paying down its debt.
4. Net Issuance of Preferred Stock:
A company may raise cash from issuing new preferred shares. It can also use cash to buy back preferred shares. If this number is positive, it means that the company has received more cash from issuing preferred shares than it has paid to buy back preferred shares. If this number is negative, it means that company has paid more cash to buy back preferred shares than it has received for issuing preferred shares.
Sisram Medical's net issuance of preferred for the
six
months ended in Dec. 2023 was $0.0 Mil.
Sisram Medical paid$0.0 Mil more to buy back preferred shares than it received from issuing preferred shares.
5. Cash Flow for Dividends:
Cash flow for dividends refers to the payment of cash to shareholders as dividends when the company generates income.
Sisram Medical's cash flow for dividends for the
six
months ended in Dec. 2023 was $0.0 Mil.
Sisram Medical received$0.0 Mil from paying cash dividends to shareholders.
6. Other Financing:
Money spent or earned by company from other financial activities.
Sisram Medical's other financing for the
six
months ended in Dec. 2023 was $-11.9 Mil.
Sisram Medical spent$11.9 Mil on other financial activities.
Sisram Medical Cash Flow from Financing Related Terms
Thank you for viewing the detailed overview of Sisram Medical's Cash Flow from Financing provided by GuruFocus.com. Please click on the following links to see related term pages.
Sisram Medical (Sisram Medical) Business Description
Sisram Medical Ltd is an investment holding company specializing in medical technology for healthcare. The company is mainly involved in the design, development, manufacture, and sale of energy-based aesthetic medical and minimally invasive treatment systems, non-EBD devices and cosmeceuticals. The company's products include Soprano Titanium, Colibri technology, and others. Some of the company's brands are Alma, Soprano, Harmony, and ClearLift. It operates through the following geographical segments: Europe, North America, Asia Pacific, Latin America, and the Middle East and Africa.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
Portfolio Contest
SRAMF has been successfully added to your 